Neurologic Manifestations  >>  MK0249  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK0249 / Merck (MSD)
NCT00475735: A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

Completed
2a
72
US
MK0249, Concerta (methylphenidate), CONCERTA®, Placebo
Merck Sharp & Dohme LLC
Attention-Deficit/Hyperactivity Disorder (ADHD)
04/08
04/08

Download Options